polyinosinic polycytidylic acid (PrEP-001) / PrEP Biopharm - LARVOL DELTA

PrEP-001 prophylactic effect against rhinovirus and influenza virus - RESULTS of 2 randomized trials. (PubMed, Antiviral Res) - P2; "PrEP-001 reduced the number of individuals with clinical illness and attenuated severity and duration of HRV-A16 and H3N2-IAV infections without compromising seroconversion, and was well-tolerated. This supports further evaluation of PrEP-001 as a potential pan-viral prophylaxis for upper respiratory tract infections."

Clinical • Journal